Premium
CBD may help prevent relapse in abstinent heroin addicts
Author(s) -
Knopf Alison
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32382
Subject(s) - craving , cannabidiol , anxiety , heroin , opioid , addiction , placebo , adverse effect , drug , medicine , cannabis , psychiatry , psychology , pharmacology , receptor , alternative medicine , pathology
Cannabidiol (CBD) has the potential to reduce craving and anxiety in people with opioid use disorder who have been opioid‐free for at least a week, a recent study using Epidiolex, the Food and Drug Administration–approved form of the marijuana‐derived drug, has found. The study compared CBD to placebo in subjects who were exposed to drug‐related and non‐drug‐related‐cues, and measured craving and anxiety. CBD administration was short‐term (three days), but beneficial effects lasted seven days afterward. There were no effects on cognition and no adverse effects.